Ticlopidine and TTP after coronary stenting [1] (multiple letters)

JAMA

Volumn 282, Issue 18, 1999, Pages 1717-1719

  Bennett, C L ^a   Davidson, C J ^a   Green, D ^a   Weinberg, P D ^a   Feldman, M D ^a   McCullough, P A ^a   Marks, K R ^a   Steinhubl, S R ^a   Tan, W A ^a   Foody, J M ^a   Topol, E J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PHENYTOIN; TICLOPIDINE; WARFARIN; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; AGRANULOCYTOSIS; ANTICOAGULANT THERAPY; CARDIOLOGY; CORONARY STENT; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG STRUCTURE; DRUG SURVEILLANCE PROGRAM; HUMAN; LETTER; NEUTROPENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; CORONARY ARTERY DISEASE; NOTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; RISK; STENT;

ANGIOPLASTY, BALLOON; CORONARY DISEASE; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK; STENTS; TICLOPIDINE;

EID: 0033544389     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.18.1717     Document Type: Letter

References (0)